MedTrace Logo

Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)

NCT06306170 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-04-22

No results posted yet for this study

Summary

This is an observational mono-institutional study. Patients with gynecologic tumors treated with advanced radiotherapy- Image Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Body Radiotherapy (SBRT)- will be included and toxicity and outcomes analyzed.

Conditions

  • Gynecologic Cancer
  • Radiotherapy Side Effect
  • Radiotherapy; Complications
  • Survivorship
  • Progression, Disease
  • Progression, Clinical

Interventions

RADIATION

Image Guided Radiotherapy

Patients treated with IGRT, IMRT, SBRT for Gynecological cancer will be evaluated

Sponsors & Collaborators

  • IRCCS San Raffaele

    lead OTHER

Principal Investigators

  • andrei Fodor, MD · IRCCS San Raffaele Scientific Institute

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-15
Primary Completion
2027-02-15
Completion
2029-02-15

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06306170 on ClinicalTrials.gov